Lawrence Schwartz
Internal Medicine · Richmond, VANPI 1508955659
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Blueprint Medicines Corporation at 58.7% of the total. Reporting peaked in 2023 at $97,348 and has fallen 90.1% since, to $9,662 in 2025. Among internal medicine clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 203 payments — averaging $1012.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Blueprint Medicines Corporation$121K
- Astrazeneca UK Limited$61K
- Pharming Healthcare, Inc.$7K
- Shire North American Group Inc$5K
- AstraZeneca$3K
- GSK$3K
- plus $7K from 7 others
Across 154 payments — averaging $14,207 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Deciphera Pharmaceuticals Inc.$2M
- Blueprint Medicines Corporation$163K
- Phadia US Inc.$16K
- Shire North American Group Inc$13K
What the payments were for
- Consulting fees$97,01447%
- Speaking & faculty fees$85,73942%
- Travel & lodging$19,3479%
- Food & beverage$3,3892%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Blueprint Medicines Corporation | 129 | $120,601 |
| Astrazeneca UK Limited | 35 | $60,933 |
| Pharming Healthcare, Inc. | 9 | $6,745 |
| Shire North American Group Inc | 2 | $4,699 |
| AstraZeneca | 4 | $2,687 |
| GSK | 7 | $2,587 |
| Biocryst Pharmaceuticals, Inc. | 6 | $2,434 |
| CSL Behring | 2 | $1,794 |
| Phadia AB | 1 | $1,500 |
| Tersera Therapeutics LLC | 2 | $953 |
| Regeneron Healthcare Solutions, Inc. | 3 | $322 |
| Sanofi | 2 | $199 |
| Aimmune Therapeutics, Inc. | 1 | $34 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$205,489 in reported general payments places this provider in the 95th percentile of 2,724 internal medicine providers in Virginia.
Other internal medicine in Richmond
- Wally SmithRichmond$177K
- Andrew PoklepovicRichmond$58K
- Leroy VaughanRichmond$55K
- Rachel WallerRichmond$55K
- Syed RehmanRichmond$49K
- Rafae ShaikhRichmond$41K
- Chau VoRichmond$24K
- Richard JacksonRichmond$17K
- Minh TranRichmond$16K
- Thokozeni LipatoRichmond$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.